 | • レポートコード：STR-DC015 • 出版社/出版日：Straits Research / 2019年11月28日 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名様用、印刷不可） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Multi User（5名様用） | ￥836,200 (USD5,650) | ▷ お問い合わせ |
| Enterprise Price（法人閲覧用） | ￥1,073,000 (USD7,250) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートでは、MRIにおける造影剤の世界市場について調査・分析し、調査手法、市場概要、種類別（バリウムベース、ヨウ素化、ガドリニウムベース、マイクロバブル、手術センター、その他）分析、用途別（腫瘍学、循環器学、神経学、炎症、その他）分析、地域別分析、企業概要などを含め次の構成でお届け致します。 ・イントロダクション ・調査手法 ・市場概要 ・MRIにおける造影剤の世界市場：種類別（バリウムベース、ヨウ素化、ガドリニウムベース、マイクロバブル、手術センター、その他） ・MRIにおける造影剤の世界市場：用途別（腫瘍学、循環器学、神経学、炎症、その他） ・MRIにおける造影剤の世界市場：地域別 ・企業概要 |
Global contrast agents in MRI market accounted for approximately USD 4,353.2 million in 2018 and is expected to grow at a CAGR of 4.0 % during the forecast period, 2019–2026.
MRI contrast agents are used to improve the visibility of internal body structures in magnetic resonance imaging (MRI). It is widely used in compounds for contrast enhancement are gadolinium-based. Furthermore, the company spends millions of dollars on R&D to find appropriate agents. For instance, GE Healthcare and Schering AG spend approximately 10%–15% of the total MRI contrast agent’s sales revenue on its research & development. Thus, any company can increase the profit margin on the products by decreasing the cost of bringing a drug to the market.
Increasing prevalence of chronic diseases such as cardiac conditions and cancer are key factors projected to drive the demand for contrast agents for MRI market. For instance, according to the International Agency for Research on Cancer, around 18 million new cases were diagnosed with cancer in 2018. Thus, increasing prevalence of cancer and rising mortality rate are demanding effective diagnosis through diagnostic procedures such as MRI.
Segmental Insights
The global contrast agents for magnetic resonance imaging (MRI) market is segmented on the basis of type and application.
Based on type, the market is segmented into barium-based contrast media, iodinated contrast media, gadolinium-based contrast media, and microbubble contrast media. Iodinated contrast media valued USD 1,889.4 million in 2017 and is projected to dominate the market in the coming years. Barium-based contrast media segment is expected to grow at the highest CAGR of 4.3% during the forecast period 2018–2025. Barium-based contrast media is commonly used in the diagnostic examinations of the diseases related to stomach, esophagus, small intestine, large intestine, and pharynx. For the diagnostic tests of diseases related to the gastrointestinal tract, barium-based contrast media is administered rectally by enema.
In the basis of application, market is bifurcated into radiology, interventional radiology, and interventional cardiology. Cardiology is the fastest growing segment and is expected to reach USD 1521.2 million by 2025 at a healthy CAGR of 4.2%. This is attributed to increasing prevalence of cardiac diseases, growing incidences of sudden cardiac arrests and increasing complexity of congenital heart diseases are positively influencing the growth of the cardiology segment. For instance, according to the American Heart Association, the global number of patients suffering from cardiac diseases is expected to reach 23.6 million by 2030.
Regional Insights
Geographically, the global contrast agents in MRI Market is segmented into four North America, Europe, Asia Pacific, and Latin America and the Middle East & Africa (LAMEA).
North America is expected to hold major share for global contrast agents in MRI Market.
High prevalence of cardiac diseases in this region is propelling the growth of market. For instance, additionally, according to the Sudden Cardiac Arrest Foundation in 2018, more than 356,000 people experienced sudden cardiac arrest in the U.S. Effective diagnosis of chronic diseases is feasible using contrast agent in MRI diagnostic procedures. Increasing research & development in this region is boosting the growth of market. In February 2016, the U.S. Food and Drug Administration approved first barium-based contrast agent by Bracco Diagnostics to be used for diagnostic tests. Furthermore, high presence of geriatric patient suffering from various chronic diseases is boosting the growth of market.
Europe is expected to second leading region for global contrast agents in MRI Market. Various company entered in collaboration and acquisition of leading players for innovation of product is propelling the growth of market. For instance, in 2018, Guerbet LLC acquired Accurate Medical Therapeutics, an innovative company that develops microcatheters for interventional radiology. Increasing research & development of new product is support the growth of market. For instance, additionally, in 2017, the company launched Vectorio an innovative medical device for Interventional Imaging. Furthermore, high prevalence of chronic diseases in this region is propelling the growth of market. For instance, according to the Macmillan Cancer Support, around 198 rare types of cancers have an incidence rate of six in one million people in the U.K
Key Players
Some of the key players of global contrast agents in MRI Market include Unijules Life Sciences Ltd.(India), Spago Nanomedical AB(Sweden), Lantheus Medical Imaging, Inc.(U.S.) , J.B. Chemicals and Pharmaceuticals Limited(India), Guerbet LLC(France), GE Healthcare(U.S.), Daiichi Sankyo Company, Limited(Japan), Bracco Imaging S.p.A.( Italy), Bayer Healthcare AG(Germany), Jodas Expoim(India), Magnus Health(India).
TABLE OF CONTENT
1 Introduction
1.1 Market Definition
1.2 Market Scope
2 Research Methodology
2.1 Primary Research
2.2 Research Methodology
2.3 Assumptions & Exclusions
2.4 Secondary Data Sources
3 Market Overview
3.1 Report Segmentation & Scope
3.2 Value Chain Analysis: Global Contrast Agents in MRI Market
3.3 Key Market Trends
3.3.1 Drivers
3.3.2 Restraints
3.3.3 Opportunities
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Threat of Substitution
3.4.4 Threat of New Entrants
3.4.5 Competitive Rivalry
4. By Type
4.1 Introduction
4.1.1 Market Size & Forecast (Value)
4.2 Barium Based
4.3 Iodinated
4.4 Gadolinium Based
4.5 Microbubble
4.6 Surgical Centers
4.7 Others
5. By Application
5.1 Introduction
5.1.1 Market Size & Forecast (Value)
5.2 Oncology
5.3 Cardiology
5.4 Neurology
5.5 Inflammations
5.6 Others
6. By Regional Overview
6.1 Introduction
6.1.1 Market Size & Forecast (Value)
6.2 America
6.2.1 North America
6.2.1.1 U.S.
6.2.1.1.1 By Type
6.2.1.1.2 By Application
6.2.1.2 Canada
6.2.1.2.1 By Type
6.2.1.2.2 By Application
6.2.1.3 Mexico
6.2.1.3.1 By Type
6.2.1.3.2 By Application
6.2.2 South America
6.2.2.1 By Type
6.2.2.2 By Application
6.3 Europe
6.3.1 Market Size & Forecast (Value)
6.3.2 Western Europe
6.3.2.1 Germany
6.3.2.1.1 By Type
6.3.2.1.2 By Application
6.3.2.2 France
6.3.2.2.1 By Type
6.3.2.2.2 By Application
6.3.2.3 U.K
6.3.2.3.1 By Type
6.3.2.3.2 By Application
6.3.2.4 Italy
6.3.2.4.1 By Type
6.3.2.4.2 By Application
6.3.2.5 Spain
6.3.2.5.1 By Type
6.3.2.5.2 By Application
6.3.2.6 Rest of Western Europe
6.3.2.6.1 By Type
6.3.2.6.2 By Application
6.3.3 Eastern Europe
6.4 Asia Pacific
6.4.1 Market Size & Forecast (Value)
6.4.2 China
6.4.2.1 By Type
6.4.2.2 By Application
6.4.3 India
6.4.3.1 By Type
6.4.3.2 By Application
6.4.4 Japan
6.4.4.1 By Type
6.4.4.2 By Application
6.4.5 South Korea
6.4.5.1 By Type
6.4.5.2 By Application
6.4.6 Australia
6.4.6.1 By Type
6.4.6.2 By Application
6.4.6 Rest of Asia-Pacific
6.4.7.1 By Type
6.4.7.2 By Application
6.5 Middle East & Africa
6.5.1 Market Size & Forecast (Value)
6.5.2 The Middle East
6.5.2.1 South Africa
6.5.2.1.1 By Type
6.5.2.1.2 By Application
6.5.2.2 UAE
6.5.2.2.1 By Type
6.5.2.2.2 By Application
6.5.2.3 Qatar
6.5.2.3.1 By Type
6.5.2.3.2 By Application
6.5.2.4 Rest of Middle East
6.5.2.4.1 By Type
6.5.2.4 2 By Application
6.5.3 Africa
6.5.3.1 By Type
6.5.3.2 By Application
7. Company Profile
9.1 Unijules Life Sciences Ltd.
7.1.1 Company Overview
7.1.2 Financial Performance
7.1.3 Recent Developments
7.1.4 Product Portfolio
7.2 Spago Nanomedical AB
7.2.1 Company Overview
7.2.2 Financial Performance
7.2.3 Recent Developments
7.2.4 Product Portfolio
7.3 Lantheus Medical Imaging, Inc.
7.3.1 Company Overview
7.3.2 Financial Performance
7.3.3 Recent Developments
7.3.4 Product Portfolio
7.4 J.B. Chemicals and Pharmaceuticals Limited
7.4.1 Company Overview
7.4.2 Financial Performance
7.4.3 Recent Developments
7.4.4 Product Portfolio
7.5 Guerbet LLC
7.5.1 Company Overview
7.5.2 Financial Performance
7.5.3 Recent Developments
7.5.4 Product Portfolio
7.6 GE Healthcare
7.6.1 Company Overview
7.6.2 Financial Performance
7.6.3 Recent Developments
7.6.4 Product Portfolio
7.7 Daiichi Sankyo Company, Limited
7.7.1 Company Overview
7.7.2 Financial Performance
7.7.3 Recent Developments
7.7.4 Product Portfolio
7.8 Bracco Imaging S.p.A.
7.8.1 Company Overview
7.8.2 Financial Performance
7.8.3 Recent Developments
7.8.4 Product Portfolio
7.9 Bayer Healthcare AG
7.9.1 Company Overview
7.9.2 Financial Performance
7.9.3 Recent Developments
7.9.4 Product Portfolio
7.10 Jodas Expoim
7.10.1 Company Overview
7.10.2 Financial Performance
7.10.3 Recent Developments
7.10.4 Product Portfolio
TABLE 1 Global Contrast Agents in MRI Market Share, By Type, 2016-2026 ($Million)
TABLE 2 Barium Based Market Share, By Region, 2016-2026 ($ Million)
TABLE 3 Iodinated Market Share, By Region, 2016-2026, ($ Million)
TABLE 4 Global Contrast Agents in MRI Market Share, By Application 2016-2026 ($Million)
TABLE 5 Oncology Market Share, By Region, 2016-2026 ($ Million)
TABLE 6 Cardiology Market Share, By Region, 2016-2026 ($ Million)
TABLE 7 Global Contrast Agents in MRI Market Share Value, 2016-2026 ($Million)
TABLE 8 Global Contrast Agents in MRI Market Share By Region, 2016-2026 ($ Million)
TABLE 9 America Global Contrast Agents in MRI Market Share Value, By Country, 2016-2026 ($Million)
TABLE 10 America Global Contrast Agents in MRI Market Share value, By Type, 2016-2026 ($Million)
TABLE 11 America Global Contrast Agents in MRI Market Share value, By Application, 2016-2026 ($Million)
TABLE 12 U.S. Global Contrast Agents in MRI Market Share, By Type, 2016-2026 ($Million)
TABLE 13 U.S. Global Contrast Agents in MRI Market Share, By Application, 2016-2026 ($Million)
TABLE 14 Canada Global Contrast Agents in MRI Market Share, By Type, 2016-2026 ($Million)
TABLE 15 Canada Global Contrast Agents in MRI Market Share, By Application 2016-2026 ($Million)
TABLE 16 Mexico Global Contrast Agents in MRI Market Share, By Type, 2016-2026 ($Million)
TABLE 17 Mexico Global Contrast Agents in MRI Market Share, By Application 2016-2026 ($Million)
TABLE 18 South America Global Contrast Agents in MRI Market Share, By Type, 2016-2026 ($Million)
TABLE 19 South America Global Contrast Agents in MRI Market Share, By Application 2016-2026 ($Million)
TABLE 20 Europe Global Contrast Agents in MRI Market Share Value, By Region, 2016-2026 ($Million)
TABLE 21 Europe Global Contrast Agents in MRI Market Share, By Type, 2016-2026 ($Million)
TABLE 22 Europe Global Contrast Agents in MRI Market Share, By Application 2016-2026 ($Million)
TABLE 23 Western Europe Global Contrast Agents in MRI Market Share Value, By Country, 2016-2026 ($Million)
TABLE 24 Western Europe Global Contrast Agents in MRI Market Share, By Type, 2016-2026 ($Million)
TABLE 25 Western Europe Global Contrast Agents in MRI Market Share, By Application 2016-2026 ($Million)
TABLE 26 Germany Global Contrast Agents in MRI Market Share, By Type, 2016-2026 ($Million)
TABLE 27 Germany Global Contrast Agents in MRI Market Share, By Application 2016-2026 ($Million)
TABLE 28 France Global Contrast Agents in MRI Market Share, By Type, 2016-2026 ($Million)
TABLE 29 France Global Contrast Agents in MRI Market Share, By Application 2016-2026 ($Million)
TABLE 30 UK Global Contrast Agents in MRI Market Share, By Type, 2016-2026 ($Million)
TABLE 31 UK Global Contrast Agents in MRI Market Share, By Application 2016-2026 ($Million)
TABLE 32 Italy Global Contrast Agents in MRI Market Share, By Type, 2016-2026 ($Million)
TABLE 33 Italy Global Contrast Agents in MRI Market Share, By Application 2016-2026 ($Million)
TABLE 34 Spain Global Contrast Agents in MRI Market Share, By Type, 2016-2026 ($Million)
TABLE 35 Spain Global Contrast Agents in MRI Market Share, By Application, 2016-2026 ($Million)
TABLE 36 Rest of Western Europe Global Contrast Agents in MRI Market Share, By Type, 2016-2026 ($Million)
TABLE 37 Rest of Western Europe Global Contrast Agents in MRI Market Share, By Application, 2016-2026 ($Million)
TABLE 38 Eastern Europe Global Contrast Agents in MRI Market Share, By Type, 2016-2026 ($Million)
TABLE 39 Eastern Europe Global Contrast Agents in MRI Market Share, By Application 2016-2026 ($Million)
TABLE 40 Asia-Pacific Global Contrast Agents in MRI Market Share, By Country, 2016-2026 ($Million)
TABLE 41 Asia-Pacific Global Contrast Agents in MRI Market Share, By Type, 2016-2026 ($Million)
TABLE 42 Asia-Pacific Global Contrast Agents in MRI Market Share, By Application, 2016-2026 ($Million)
TABLE 43 Japan Global Contrast Agents in MRI Market Share, By Type, 2016-2026 ($Million)
TABLE 44 Japan Global Contrast Agents in MRI Market Share, By Application, 2016-2026 ($Million)
TABLE 45 China Global Contrast Agents in MRI Market Share, By Type, 2016-2026 ($Million)
TABLE 46 China Global Contrast Agents in MRI Market Share, By Application, 2016-2026 ($Million)
TABLE 47 Australia Global Contrast Agents in MRI Market Share, By Type, 2016-2026 ($Million)
TABLE 48 Australia Global Contrast Agents in MRI Market Share, By Application, 2016-2026 ($Million)
TABLE 49 India Global Contrast Agents in MRI Market Share, By Type, 2016-2026 ($Million)
TABLE 50 India Global Contrast Agents in MRI Market Share, By Application, 2016-2026 ($Million)
TABLE 51 South Korea Global Contrast Agents in MRI Market Share, By Type, 2016-2026 ($Million)
TABLE 52 South Korea Global Contrast Agents in MRI Market Share, By Application 2016-2026 ($Million)
TABLE 53 Rest of Asia-pacific Global Contrast Agents in MRI Market Share, By Type, 2016-2026 ($Million)
TABLE 54 Rest of Asia-pacific Global Contrast Agents in MRI Market Share, By Application, 2016-2026 ($Million)
TABLE 55 The Middle East and Africa Global Contrast Agents in MRI Market Share, By Region, 2016-2026 ($Million)
TABLE 56 The Middle East and Africa Global Contrast Agents in MRI Market Share, By Type, 2016-2026 ($Million)
TABLE 57 The Middle East and Africa Global Contrast Agents in MRI Market Share, By Application, 2016-2026 ($Million)
TABLE 58 The Middle East Global Contrast Agents in MRI Market Share, By Country, 2016-2026 ($Million)
TABLE 59 The Middle East Global Contrast Agents in MRI Market Share, By Type, 2016-2026 ($Million)
TABLE 60 The Middle East Global Contrast Agents in MRI Market Share, By Application, 2016-2026 ($Million)
TABLE 61 Saudi Arabia Global Contrast Agents in MRI Market Share, By Type, 2016-2026 ($Million)
TABLE 62 Saudi Arabia Global Contrast Agents in MRI Market Share, By Application, 2016-2026 ($Million)
TABLE 63 UAE Global Contrast Agents in MRI Market Share, By Type, 2016-2026 ($Million)
TABLE 64 UAE Global Contrast Agents in MRI Market Share, By Application, 2016-2026 ($Million)
TABLE 65 Qatar Global Contrast Agents in MRI Market Share, By Type, 2016-2026 ($Million)
TABLE 66 Qatar Global Contrast Agents in MRI Market Share, By Application, 2016-2026 ($Million)
TABLE 67 Africa Global Contrast Agents in MRI Market Share, By Country, 2016-2026 ($Million)
TABLE 68 Africa Global Contrast Agents in MRI Market Share, By Type, 2016-2026 ($Million)
TABLE 69 Africa Global Contrast Agents in MRI Market Share, By Application, 2016-2026 ($Million)
List of Figures
FIGURE 1 Global Contrast Agents in MRI Market Overview
FIGURE 2 Value Chain Analysis
FIGURE 3 Bargaining Power of Suppliers
FIGURE 4 Bargaining Power of Buyers
FIGURE 5 Threat of Substitutes
FIGURE 6 Threat of New Entrants
FIGURE 7 Competitive Rivalry
FIGURE 8 Global Contrast Agents in MRI Market, 2016-2026
FIGURE 9 U.S. Global Contrast Agents in MRI Market Share, 2016-2026 ($Million)
FIGURE 10 Canada Global Contrast Agents in MRI Market Share, 2016-2026 ($Million)
FIGURE 11 Mexico Global Contrast Agents in MRI Market Share, 2016-2026 ($Million)
FIGURE 12 South America Global Contrast Agents in MRI Market Share, 2016-2026 ($Million)
FIGURE 13 Western Europe Global Contrast Agents in MRI Market Share, 2016-2026 ($Million)
FIGURE 14 Germany Global Contrast Agents in MRI Market Share, 2016-2026 ($Million)
FIGURE 15 France Global Contrast Agents in MRI Market Share, 2016-2026 ($Million)
FIGURE 16 UK Global Contrast Agents in MRI Market Share, 2016-2026 ($Million)
FIGURE 17 Italy Global Contrast Agents in MRI Market Share, 2016-2026 ($Million)
FIGURE 18 Spain Global Contrast Agents in MRI Market Share, 2016-2026 ($Million)
FIGURE 19 Rest of Western Europe Global Contrast Agents in MRI Market Share, 2016-2026 ($Million)
FIGURE 20 Eastern Europe Global Contrast Agents in MRI Market Share, 2016-2026 ($Million)
FIGURE 21 Japan Global Contrast Agents in MRI Market Share, 2016-2026 ($Million)
FIGURE 22 China Global Contrast Agents in MRI Market Share, 2016-2026 ($Million)
FIGURE 23 Australia Global Contrast Agents in MRI Market Share, 2016-2026 ($Million)
FIGURE 24 India Global Contrast Agents in MRI Market Share, 2016-2026 ($Million)
FIGURE 25 South Korea Global Contrast Agents in MRI Market Share, 2016-2026 ($Million)
FIGURE 26 Rest of Asia-pacific Global Contrast Agents in MRI Market Share, 2016-2026 ($Million)
FIGURE 27 The Middle East Global Contrast Agents in MRI Market Share, 2016-2026 ($Million)
FIGURE 28 Saudi Arabia Global Contrast Agents in MRI Market Share, 2016-2026 ($Million)
FIGURE 29 UAE Global Contrast Agents in MRI Market Share, 2016-2026 ($Million)
FIGURE 30 Qatar Global Contrast Agents in MRI Market Share, 2016-2026 ($Million)
FIGURE 31 Rest of The Middle East Global Contrast Agents in MRI Market Share, 2016-2026 ($Million)
FIGURE 32 Africa Global Contrast Agents in MRI Market Share, 2016-2026 ($Million)
FIGURE 33 Unijules Life Sciences Ltd.: Revenue Analysis, ($ million)
FIGURE 34 Unijules Life Sciences Ltd.: Segment Revenue 2017 (%)